Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the USA: A Cohort Study from the FOUNTAIN Platform.
Saved in:
| Title: | Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the USA: A Cohort Study from the FOUNTAIN Platform. |
|---|---|
| Authors: | Kovesdy CP; Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.; Nephrology Section, Memphis VA Medical Center, Memphis, Tennessee, USA., Ebert N; Institute of Public Health, Charité Universitätsmedizin Berlin, Berlin, Germany., Vizcaya D; Medical, Pharmaceuticals, Integrated Evidence Generation and Business Insights, Bayer Hispania, S.L., Sant Joan Despí, Spain., Walsh M; The Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.; Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Kosiborod MN; Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.; University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA., Layton JB; RTI Health Solutions, Durham, North Carolina, USA., Ziemiecki R; RTI Health Solutions, Durham, North Carolina, USA., Johannes CB; RTI Health Solutions, Waltham, Massachusetts, USA., Pladevall-Vila M; RTI Health Solutions, Durham, North Carolina, USA.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, Michigan, USA., Gee PO; Founder and CEHD, iAdvocate, Inc, North Chesterfield, Virginia, USA., Jefferson N; Kidney Precision Medicine Project Community Engagement Committee, Dallas, Texas, USA., Chicoye A; Sciences Po Paris, Paris, France., Lopes M; AMC Health, New York, New York, USA., Thapa BB; OM1, Inc, Boston, Massachusetts, USA., Curhan G; OM1, Inc, Boston, Massachusetts, USA., Rangel L; OM1, Inc, Boston, Massachusetts, USA., Bhartia M; OM1, Inc, Boston, Massachusetts, USA., Liu F; Medical Affairs and Pharmacovigilance, Pharmaceuticals, OS Operations 2, IEG Study Operations, Bayer AG, Wuppertal, Germany., Farjat AE; Pharmaceuticals, Statistics and Data Insights, Bayer plc, Reading, UK., Oberprieler NG; Pharmaceuticals, MA & PV, Integrated Evidence Generation and Business Innovation, Bayer AS, Oslo, Norway. |
| Source: | Nephron [Nephron] 2025; Vol. 149 (7), pp. 371-383. Date of Electronic Publication: 2025 Feb 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 0331777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2235-3186 (Electronic) Linking ISSN: 16608151 NLM ISO Abbreviation: Nephron Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2235-3186 |
|---|---|
| DOI: | 10.1159/000543923 |
